Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX) started the day on May 03, 2021, with a price increase of 6.33% at $4.87. During the day, the stock rose to $4.90 and sunk to $4.57 before settling in for the price of $4.58 at the close. Taking a more long-term approach, CPRX posted a 52-week range of $2.88-$5.19.
Meanwhile, its Annual Earning per share during the time was 37.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 134.70%. This publicly-traded company’s shares outstanding now amounts to $103.70 million, simultaneously with a float of $96.41 million. The organization now has a market capitalization sitting at $524.45 million. At the time of writing, stock’s 50-day Moving Average stood at $4.27, while the 200-day Moving Average is $3.76.
It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 74 workers. It has generated 1,609,092 per worker during the last fiscal year. Meanwhile, its income per employee was 1,013,284. The stock had 14.41 Receivables turnover and 0.78 Total Asset turnover. For the Profitability, stocks gross margin was +85.69, operating margin was +34.69 and Pretax Margin of +35.18.
Catalyst Pharmaceuticals Inc. (CPRX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Catalyst Pharmaceuticals Inc.’s current insider ownership accounts for 7.00%, in contrast to 66.10% institutional ownership. According to the most recent insider trade that took place on Dec 22, this organization’s Chief Medical Officer sold 3,668 shares at the rate of 3.45, making the entire transaction reach 12,644 in total value, affecting insider ownership by 10,998. Preceding that transaction, on Sep 30, Company’s Director bought 7,000 for 2.99, making the whole transaction’s value amount to 20,930. This particular insider is now the holder of 560,376 in total.
Catalyst Pharmaceuticals Inc. (CPRX) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 12/30/2020, the organization reported $0.11 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at $0.09) by $0.02. This company achieved a net margin of +62.97 while generating a return on equity of 58.30. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.09 per share during the current fiscal year.
Catalyst Pharmaceuticals Inc.’s EPS increase for this current 12-month fiscal period is 134.70% and is forecasted to reach 0.46 in the upcoming year.
Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX) Trading Performance Indicators
Let’s observe the current performance indicators for Catalyst Pharmaceuticals Inc. (CPRX). It’s Quick Ratio in the last reported quarter now stands at 6.80. The Stock has managed to achieve an average true range (ATR) of 0.20. Alongside those numbers, its PE Ratio stands at $6.91, and its Beta score is 1.30. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.40.
In the same vein, CPRX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.70, a figure that is expected to reach 0.09 in the next quarter, and analysts are predicting that it will be 0.46 at the market close of one year from today.
Technical Analysis of Catalyst Pharmaceuticals Inc. (CPRX)
If we take a close look at the recent performances of Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX), its last 5-days Average volume was 1.12 million that shows plunge from its year to date volume of 1.64 million. During the previous 9 days, stock’s Stochastic %D was recorded 78.19% While, its Average True Range was 0.20.
Raw Stochastic average of Catalyst Pharmaceuticals Inc. (CPRX) in the period of the previous 100 days is set at 89.89%, which indicates a major fall in contrast to 95.15% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 38.16% that was lower than 51.43% volatility it exhibited in the past 100-days period.